Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced dementia].

Taro Kojima, Masahiro Akishita

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |March 31, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Certain medications can cause cognitive impairment and dementia. Avoiding polypharmacy and managing anticholinergic burden are key to preventing drug-induced dementia, especially in older adults.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association of Intensive Cognitive Rehabilitation With Discharge to Home.

    Journal of the American Medical Directors Association·2026
    Same author

    Nationwide Real-World Modeling of Surgical Outcomes in Elderly Patients: Incorporating Geriatric-Specific Risk Factors Into Prediction of Mortality and Morbidity.

    Annals of gastroenterological surgery·2026
    Same author

    Co-Production of Behavior Change Intervention Promoting an Anti-Inflammatory Diet for Frailty Prevention in Community-Dwelling Older Adults.

    Nutrients·2026
    Same author

    Combined Effects of Protein/Fat Deficiency and Disuse on Skeletal Muscle Mass and Function in Mice.

    Geriatrics & gerontology international·2026
    Same author

    Impact of financial incentive for team-based dementia care on patient outcomes in acute-care hospitals in Japan: a difference-in-differences analysis.

    BMJ quality & safety·2026
    Same author

    HQ5: Do Intervention and Evaluation Using Digital Health Services Prevent Sarcopenia in High-Risk Non-Older Adults? English Translation of the Japanese Guideline for Digital Health for the Prevention and Improvement of Sarcopenia and Frailty.

    Geriatrics & gerontology international·2026

    Area of Science:

    • Pharmacology
    • Geriatrics
    • Neurology

    Context:

    • Medications are frequently associated with adverse cognitive effects, including delirium, cognitive impairment, and dementia.
    • Specific drug classes, such as antihypertensives and oral antidiabetics, can lead to dementia through prolonged hypotension or hypoglycemia.
    • The cumulative effect of anticholinergic drugs poses a significant risk for cognitive decline, particularly in patients with pre-existing dementia.

    Purpose:

    • To review the association between drug use and cognitive impairment, including dementia.
    • To highlight the risks of specific drug classes and anticholinergic burden on cognitive function.
    • To emphasize preventive strategies and early diagnostic measures for drug-induced dementia.

    Summary:

    • Drug-induced dementia is a recognized clinical entity linked to various medications.

    Related Experiment Videos

  • Polypharmacy and high anticholinergic burden are significant risk factors for cognitive decline.
  • Preventive measures include judicious prescribing, avoiding polypharmacy, and adopting a 'start low, go slow' approach.

    • Impact:

    • Early identification and cessation of causative agents can improve cognitive outcomes.
    • Awareness of drug-induced cognitive impairment is crucial for healthcare providers, especially in geriatric care.
    • Minimizing anticholinergic burden and polypharmacy can enhance patient safety and cognitive health.